Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Enovis Corporation (ENOV : NYSE)

• Company Description    Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. Number of Employees: 7,802

• Price / Volume Information    Yesterday's Closing Price: $25.47 Daily Weekly Monthly 20 Day Moving Average: 1,164,361 shares Shares Outstanding: 57.24 (millions) Market Capitalization: $1,458.03 (millions) Beta: 1.46 52 Week High: $40.70 52 Week Low: $21.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 15.56% 16.57% 12 Week -5.74% -5.85% Year To Date -4.39% -4.86%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2711 Centerville Road Suite 400 - Wilmington,DE 19808 USA ph: 302-252-9160 fax: 301-323-9001 investorrelations@enovis.com http://www.enovis.com

• General Corporate Information    Officers Damien McDonald - Chief Executive Officer and Director Phillip B. Berry - Senior Vice President and Chief Financial Officer Oliver Engert - Chief Administrative Officer Bradley J. Tandy - Senior Vice President and Chief Legal Officer Patricia Lang - Senior Vice President and Chief Human Resources Of Peer Information Enovis Corporation (HLIS) Enovis Corporation (AZTA) Enovis Corporation (APYI) Enovis Corporation (RNVA) Enovis Corporation (HMSY) Enovis Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 194014502 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 57.24 Most Recent Split Date: 4.00 (0.33:1) Beta: 1.46 Market Capitalization: $1,458.03 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.80 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.62 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: 7.03 Trailing 12 Months: 7.72 PEG Ratio: - Price Ratios Price/Book: 0.98 Price/Cash Flow: 0.95 Price / Sales: 0.65 EPS Growth vs. Year Ago Period: -3.06% vs. Previous Quarter: 26.67% Sales Growth vs. Year Ago Period: 2.64% vs. Previous Quarter: 4.89% ROE 12/31/25 - 8.74 09/30/25 - 7.79 06/30/25 - 6.78 ROA 12/31/25 - 4.19 09/30/25 - 4.00 06/30/25 - 3.73 Current Ratio 12/31/25 - 2.02 09/30/25 - 2.22 06/30/25 - 2.25 Quick Ratio 12/31/25 - 1.04 09/30/25 - 1.16 06/30/25 - 1.15 Operating Margin 12/31/25 - 8.47 09/30/25 - 8.54 06/30/25 - 8.60 Net Margin 12/31/25 - -52.69 09/30/25 - -61.22 06/30/25 - -37.80 Pre-Tax Margin 12/31/25 - -51.57 09/30/25 - -59.27 06/30/25 - -36.51 Book Value 12/31/25 - 26.09 09/30/25 - 35.40 06/30/25 - 45.18 Inventory Turnover 12/31/25 - 1.50 09/30/25 - 1.57 06/30/25 - 1.57 Debt-to-Equity 12/31/25 - 0.85 09/30/25 - 0.66 06/30/25 - 0.53 Debt-to-Capital 12/31/25 - 45.82 09/30/25 - 39.83 06/30/25 - 34.73

Powered by Zacks Investment Research ©